Deactivating implantable cardiac defibrillators in end of life care. Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014

Similar documents
Specialised Services Policy Position PP151

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

New scientific documents from EHRA Management of patients with defibrillator shocks

Deactivating the shock function of an implantable cardioverter defibrillator (ICD) towards the end of life

Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death

NORTH OF ENGLAND CARDIOVASCULAR NETWORK (NECVN)

CRT-P or CRT-D From North Alberta to Nairobi

NHS. Implantable cardioverter defibrillators (ICDs) for arrhythmias. National Institute for Health and Clinical Excellence. Issue date: January 2006

Cardiac resynchronisation therapy (biventricular pacing) for the treatment of heart failure

Tachycardia Devices Indications and Basic Trouble Shooting

Cardiac Devices CRT,ICD: Who is and is not a Candidate? Who Decides

MADIT Studies: CRT in the Non-LBBB Patient and Other Findings. Arthur J. Moss, MD

Title Deactivation of Implantable Cardioverter Defibrillators (ICD) towards the end of life Guidelines

ICDs - decisions at the end of life

ICD THERAPIES: are they harmful or just high risk markers?

Flowchart for ICD patients undergoing Surgery or procedures involving diathermy/magnetic fields

ICD deactivation Patient Journey

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Cardiac Resynchronisation Therapy Defibrillator (CRT-D)

Large RCT s of CRT 2002 to present

Peri-operative management of pacemakers and implantable cardiac defibrillators

Arrhythmia Care in the DGH What Still Needs to be Done? Dr. Sundeep Puri Consultant Cardiologist

Dialysis-Dependent Cardiomyopathy Patients Demonstrate Poor Survival Despite Reverse Remodeling With Cardiac Resynchronization Therapy

Proposal for the development of Guidelines for the De-activation. of Implantable Cardiac Defibrillators in End of Life Care

ACD Heart failure - biventricular pacing (cardiac resynchronisation)

Silvia G Priori MD PhD

Cardiac Resynchronization ICD Therapy: What is New?

Who does not need a primary preventive ICD?

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

Cardiac Arrest Survivors and Implantable Defibrillator Recipients:

SPORTS AND EXERCISE ADVICE IN PATIENTS WITH ICD AND PPM

Need to Know: Implantable Devices. Carolyn Brown RN, MN, CCRN Education Coordinator Emory Healthcare Atlanta, Georgia

Technology appraisal guidance Published: 25 June 2014 nice.org.uk/guidance/ta314

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

What You Should Know About Subcutaneous and Transvenous ICD

Defibrillation threshold testing should no longer be performed: contra

A patient with heart failure and resynchronisation/ about training and exercise?

Supplemental Material

Treatment of VT of Purkinje fiber origin: ablation targets and outcome

The Interface of Cardiology and Palliative Medicine

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

The Role of ICD Therapy in Cardiac Resynchronization

USE OF ACCELEROMETER DATA TO EVALUATE PHYSICAL ACTIVITY AS A SURROGATE ENDPOINT IN HEART FAILURE CLINICAL TRIALS. Tracy Bergemann PhD

Primary prevention of SCD with the ICD in Nonischemic Cardiomyopathy

Prognostic Importance of Defibrillator Shock

Comparison of clinical trials evaluating cardiac resynchronization therapy in mild to moderate heart failure

Do All Patients With An ICD Indication Need A BiV Pacing Device?

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

Syncope in Heart Failure Patients How to judge and treat? Jean-Claude Deharo, MD, FESC Marseilles, France

Antony French Consultant Cardiologist & Electrophysiologist

The implantable cardioverter defibrillator is not enough: Ventricular Tachycardia Catheter Ablation in Patients with Structural Heart Disease

Risk Stratification of Sudden Cardiac Death

Devices and Other Non- Pharmacologic Therapy in CHF. Angel R. Leon, MD FACC Division of Cardiology Emory University School of Medicine

Emergency Department Management of Patients with Implantable Cardioverter Defibrillators

Gender and cardiac resynchronization therapy. Chairs: David Heaven & Belinda Green. Gender and Cardiac Resynchronisation Therapy

Continuous ECG telemonitoring with implantable devices: the expected clinical benefits

Endpoints When Treating VT/VF in Patients with ICDs Programming Wojciech Zareba, MD, PhD

Importance of CRT team for optimization of the results: a European point of view

Device detected VT: How much VT is significant and is VT ablation the answer?

Cardiac Arrest Survivors and Implantable Defibrillator Recipients:

Inappropriate electrical shocks: Tackling the beast

His Bundle Pacing in Bundle Branch Block May 11, 2017

Newer pacemakers also can monitor your blood temperature, breathing, and other factors and adjust your heart rate to changes in your activity.

Arthur J. Moss, MD Professor of Medicine/Cardiology University of Rochester Medical Center Rochester, NY. DISCLOSURE INFORMATION Arthur J.

Heart Failure Vital steps for palliative care. Dr Karen J Hogg Glasgow Royal Infirmary

Quality Standards for the Implantation of Cardiac Rhythm Management Devices. Pan- London Arrhythmia Project Group. Version 3 (18 th July 2011)

Device management and generator changes at end of life: what do we want to avoid? Dr Stephen Pettit, Consultant Cardiologist

Response of Right Ventricular Size to Treatment with Cardiac Resynchronization Therapy and the Risk of Ventricular Tachyarrhythmias in MADIT-CRT

Association between RV Function in PPCM and LV Recovery & Clinical Outcome

The patient with electric storm

Sudden death from abnormal heart rhythm: Am I at risk?

Αμφικοιλιακή βηματοδότηση: LBBB ή ευρύ QRS;

EBR Systems, Inc. 686 W. Maude Ave., Suite 102 Sunnyvale, CA USA

Bi-Ventricular pacing after the most recent studies

ESC Stockholm Arrhythmias & pacing

Date of Meeting: Ratified Date: 11/03/2010

Noninvasive Predictors of Sudden Cardiac Death

ΔΠΔΜΒΑΣΙΚΗ ΘΔΡΑΠΔΙΑ ΚΟΙΛΙΑΚΩΝ ΑΡΡΤΘΜΙΩΝ

NEIL CISPER TECHNICAL FIELD ENGINEER ICD/CRTD BASICS

2017 AHA/ACC/HRS Ventricular Arrhythmias and Sudden Cardiac Death Guideline. Top Ten Messages. Eleftherios M Kallergis, MD, PhD, FESC

Device Update Implantable Cardioverter Defibrillator (ICD) 박상원

Jean François Leclercq Department of Rythmology Private Hospital of Parly 2 - Le Chesnay F

Different indications for pacemaker implantation are the following:

I NON RESPONDERS ALLA CRT: UN PROBLEMA DI NON SEMPLICE SOLUZIONE

What Every Physician Should Know:

Tech Corner. ATP in the Fast VT zone

Management of RT patients with implanted cardiac devices: From recommendation to implementation

Shock Reduction Strategies Michael Geist E. Wolfson MC

Advanced Heart Failure Management. Dr Andrew Hannah Consultant Cardiologist Aberdeen Royal Infirmary

Left Ventricular Ejection Fraction >35%

Guideline-Directed Medical Therapy

How is it possible to preview acute HF?

Cardiac Resynchronization Therapy. Michelle Khoo, MD

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

BENEFIT OF CRT IN MILDLY SYMPTOMATIC HEART FAILURE RECENT DATA FROM MADIT-CRT AND RAFT

Pattarapong Makarawate MD, FHRS Assistant Professor. Division Of Cardiology Faculty of Medicine, Khon Kaen University

Implantable Cardioverter Defibrillator

The patient with (without) an ICD and heart failure: Management of electrical storm

8:30-10:30 WS #4: Cardiology :00-13:00 WS #11: Cardiology 101 (Repeated)

Is QRS width predictive of the clinical and echocardiographic response to chronic CRT in mildly symptomatic HF patients?

Transcription:

Deactivating implantable cardiac defibrillators in end of life care Dr Laurence O Toole Consultant Cardiologist STH NHS FT 20 th November 2014

Implantable Cardiac Defibrillators (ICDs) ICDs have 3 main actions 1. Bradycardia pacing 2. Anti-tachycardia pacing (ATP) 3. Shock delivery And are often allied to.. 1. Resynchronisation pacing (CRT-D)

STH Deactivation Protocol The ICD deactivation team Senior techs: Michelle Smith and Chris Drazek Phone ECG at NGH 271 4315 Need consent of supervising consultant If conditions met will ensure deactivation in 72 hours Outreach service possible but patients may be asked to attend department Urgent deactivation possible through ECG dept at NGH or the on-call ECG technician (contacted through switchboard at NGH) but patient will need to come to NGH Magnet option remains suggest discuss with on-call ECG technicians

The magnet Magnet over ICD Anti-tachycardia features disabled (only) (Magnet over PPM Continuous pacing with no sensing)

Implantable Cardiac Defibrillators (ICDs) ICDs inserted for 1. Survivors of cardiac arrest or high risk arrhythmia 2. Those at high risk of arrhythmia (i) e.g genetic conditions (Brugada, LQTS, HCM ) (ii)high risk clinical profiles e.g Post MI Cardiomyopathy

MADIT II trial

Kaplan-Meier estimates of the cumulative probability of all-cause mortality in ICD and non- ICD patients. Goldenberg I et al. Circulation. 2010;122:1265-1271 Copyright American Heart Association, Inc. All rights reserved.

Figure 1. Kaplan Meier estimates in each treatment arm. Packer D L et al. Circulation. 2009;120:2170-2176 Copyright American Heart Association, Inc. All rights reserved.

Table 1 Treatment options with ICD or CRT for people with heart failure who have left ventricular dysfunction with an LVEF of 35% or less (according to NYHA class, QRS duration and presence of LBBB) NICE 2014: LBBB + mod to severe or severe LVSD (of any cause) Consider an Implantable Cardiac Defibrillator! And (probably) patients with LVSD should have an ECG each year!

Patient perceptions of ICD shocks ICD shocks are perceived as very painful (in one study graded 4.0 on a 0 to 5 scale). After an ICD shock, patients can be immobilized, fearing that any movement or activity might trigger another shock. Individuals who experience an ICD shock relate greater levels of psychological distress, anxiety, anger, and depression than those who do not. ICD shocks lead to greater psychological distress for family members. Raitt MH JACC 2008 51(14):1366-1368

Patient perceptions of ICD shocks Electrical storms, defined as having more than 3 shocks in a 24-h period, occurs in 10% to 20% of patients during the first 2 years after ICD implantation. In some ICD patients this leads to a reactive depression, helplessness, and post-traumatic stress disorder. Raitt MH JACC 2008 51(14):1366-1368

ICD shocks at the end of life MADIT II analysis Annual rate of death with ICD in situ is 11% -17% 27% of patients with an ICD in situ get shocks in the last month of life 8% - 10% of patients with an ICD in situ receive shocks in the last 24 hours of life

ICDs and hospice care 2011 survey of 50 hospices in Oregon USA. 86% had had pt with an ICD 86% reported an adverse event relating to the ICD Of which 2/3rds relate to shock delivery 1/3 rd relate to pt or family distress related to decision to deactivate the ICD Fromme et al Am J Hosp Pall Care 2011:28;304-9

ICD deactivation: Cardiology perspectives 2010 Survey of 47 large European ICD implantation centres 62% physicians willing to deactivate defibrillators at the end of life Only 4% (i.e. 2) centres provide pre-implantation advice on ICD deactivation Marinski et al Europace 2010

ICD deactivation: Patient Perceptions Survey of patient attitudes to their outlook and benefits of therapies in 65 ambulant HF pts with an ICD Patients are very over optimistic about their outlook and prognosis Patients over-estimate the clinical benefit of their ICD by a factor of ten Stewart GC, Weintraub JR, Pratibhu PP, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010 Feb;16:106 113.

ICD deactivation: Patient Perceptions Survey of patient attitudes to their outlook and benefits of therapies in 65 ambulant HF pts with an ICD Patient preferences are hard to predict It is a common preference not to have one s defibrillator deactivated Stewart GC, Weintraub JR, Pratibhu PP, et al. Patient expectations from implantable defibrillators to prevent death in heart failure. J Card Fail. 2010 Feb;16:106 113.

The Ethics of ICD Activation Patient autonomy and self-determination must be respected If pt has capacity and has been appropriately informed and wishes for their ICD to remain active then this wish must be respected even if it is medically questionable Detailed discussion must take place with the patient and must be recorded prior to deactivation Padaletti et al: European Heart Rhythm Association Expert Cpnsensus Statement on CIED Deactivation. Europace 2010:12;1480-1489

The Ethics of ICD Deactivation If the patient lacks capacity then the provisions of the Mental Capacity Act 2005 come into force and consider taking ethical and legal advice?...

Conclusion ICDs reduce the likelihood of death but, as heart failure worsens, patients are likely to receive more frequent shocks, which cause significant pain and anxiety. Clinicians infrequently discuss ICD deactivation with patients, and most devices remain active until death. Qualitative studies have shown that patients may not fully understand how their ICDs work and develop complex psychological relationships with their devices that may contribute to a reluctance to deactivate the ICDs. Adler et al Circulation 2009:120;2597-2606

Conclusion For end-stage heart failure patients, deactivation of ICDs when death is near is advisable to avoid repeated shocks in a dying patient. Particular care should be taken to make sure that such dialogue occurs early on, while the patient is still capable of participating in the discussion, and that it is clearly documented in the medical record. Adler et al Circulation 2009:120;2597-2606

To deliver ICD deactivation The patient-carer relationship is essential and a long term clinical relationship is likely to be best Counsel patients about the possibility of a time for deactivation prior to device implantation Patient autonomy remains paramount do not override this! Take the family with you Document the details of discussions clearly Don t be afraid to ask for ethical or legal advice Contact the IICD deactivation team in ECG dept NGH The magnet is a device of last resort

STH Deactivation Protocol The ICD deactivation team Senior techs: Michelle Smith and Chris Drazek Phone ECG at NGH 271 4315 Need consent of supervising consultant If conditions met will ensure deactivation in 72 hours Outreach service possible but patients may be asked to attend department Urgent deactivation possible through ECG dept at NGH or the on-call ECG technician (contacted through switchboard at NGH) but patient will need to come to NGH Magnet option remains suggest discuss with on-call ECG technicians